Aytu Bioscience Inc (NQ: AYTU )
8.350
USD
+0.040
(+0.48%)
Streaming Delayed Price
Updated: 7:35 AM EST, Jan 26, 2021
Add to My Watchlist
Press releases about Aytu Bioscience Inc
Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 Patients
December 28, 2020
From ACCESSWIRE
Lifshitz Law Firm, P.C. Announces Investigation of AJRD, CATM, EXPC, GNBF, LNKB, NEOS, AYTU, QEP, FANG, RP, RNET, and VSAT
December 24, 2020
From PR Newswire
From PR Newswire
Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
December 15, 2020
From ACCESSWIRE
Aytu BioScience to Present at the LD Micro Virtual Investor Conference on Tuesday, December 15 at 2:20pm ET
December 14, 2020
From ACCESSWIRE
Aytu BioScience Increases Previously Announced Bought Deal Offering to $25.0 Million
December 10, 2020
From ACCESSWIRE
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.
December 10, 2020
From PR Newswire
Aytu BioScience Announces $10.0 Million Bought Deal Offering
December 10, 2020
From ACCESSWIRE
SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc.
December 10, 2020
From PR Newswire
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
December 10, 2020
From ACCESSWIRE
From PR Newswire
Innovative Software Solutions Arise for a Returning Workforce
November 18, 2020
From PR Newswire
Aytu BioScience Announces Fiscal Q1 2021 Net Revenue of $13.5 Million, an Increase of 839% Year-Over-Year
November 12, 2020
From ACCESSWIRE
Aytu BioScience to Present at the Jefferies 2020 Virtual London Healthcare Conference Wednesday, November 18 at 1:45pm ET
November 11, 2020
From ACCESSWIRE
Aytu BioScience to Report First Quarter Fiscal 2021 Results and Provide Business Update on Thursday, November 12, 2020
November 05, 2020
From ACCESSWIRE
Creative Contactless Disinfection Solutions Arise in a Time of Need
October 28, 2020
From PR Newswire
More Stringent Testing is Planned in a Bid to Return to Normalcy
October 14, 2020
From PR Newswire
From PR Newswire
Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year
October 06, 2020
From ACCESSWIRE
Aytu BioScience to Report Fourth Quarter and Full Year Fiscal 2020 Results and Provide Business Update on Tuesday, October 6, 2020
October 05, 2020
From ACCESSWIRE
Aytu BioScience to Reschedule Fourth Quarter and FY 2020 Conference Call
September 23, 2020
From ACCESSWIRE
Thinking about buying stock in Northern Dynasty Minerals, Checkpoint Therapeutics, Rigel Pharmaceuticals, Vaxart, or Aytu Bioscience?
September 17, 2020
From PR Newswire
Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020
September 16, 2020
From ACCESSWIRE
Unprecedented Global Events Lead Diagnostic Providers to Innovative Breakthroughs
September 14, 2020
From PR Newswire
Thinking about buying stock in Vaxart Inc, Aytu Bioscience, Lakeland Industries, United Airlines, or Nio Inc?
September 08, 2020
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.